Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000611974 | SCV000726521 | likely benign | not specified | 2018-01-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000631783 | SCV000752874 | likely benign | Long QT syndrome | 2024-04-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002491280 | SCV002794648 | likely benign | Long QT syndrome 13; Familial hyperaldosteronism type III | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004992400 | SCV005604453 | likely benign | Cardiovascular phenotype | 2024-06-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |